Drugs / Emdogain®
Emdogain®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02907528 | Jan → Dec 2014 | chronic periodontitis | Ohio State University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Emdogain | “enamel matrix derivative (EMD - Emdogain® Straumann, Basel, Switzerland)” NCT02907528 ↗ |
| Known as | EMD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02907528 ↗ |
| Known as | enamel matrix derivative | “enamel matrix derivative (EMD - Emdogain® Straumann, Basel, Switzerland)” NCT02907528 ↗ |
| Modality | Protein / enzyme biologic | “mixture of enamel matrix derivative proteins (EMD)” NCT02907528 ↗ |